Phenotypic and Genotypic Landscape of Sitosterolemia in China: Including a Rare Case With Nephronophthisis Authors: Dan Ding, Hongmei Wu, Fei Zhao, Bixia Zheng, Qiuxia Chen Published: 2026 ABSTRACT ABSTRACTBackgroundSitosterolemia (STSL) is a rare autosomal recessive disorder caused by mutations in ABCG5 or ABCG8, characterized by hemolytic anemia, xanthomas, and atherosclerosis. Nephronophthisis (NPHP), another autosomal recessive disorder, is characterized by its devastating progression toward renal failure.MethodsWe analyzed the clinical, laboratory, and genetic data of a Chinese boy with concurrent STSL and NPHP. Separately, we conducted a comprehensive review of the phenotypic and genotypic profiles of all previously reported STSL cases in China.ResultsThe proband presented with recurrent fever, thrombocytopenia, splenomegaly, and renal dysfunction and was initially misdiagnosed with hemophagocytic lymphohistiocytosis. Genetic testing confirmed biallelic ABCG8 mutations (c.490C>T and c.323‐1G>C) and a homozygous NPHP1 deletion. A comprehensive review of 131 Chinese STSL cases (130 from the literature) found that xanthomas, hypercholesterolemia, and elevated low‐density lipoprotein cholesterol (LDL‐C) were the most common manifestations (each with a prevalence of 82.4%), followed by splenomegaly (32.1%), thrombocytopenia (32.1%), and anemia (30.5%). Hypercholesterolemia and high LDL‐C were more common in children, whereas hematologic abnormalities and organ damage were more prevalent in adults. Mutations in ABCG5 accounted for 77.1% of patients.ConclusionsGenetic testing is crucial when clinical findings conflict with the initial diagnosis. This study summarizes the largest cohort of Chinese STSL patients to date, which may aid in the early recognition and management of this condition. Introduction Sitosterolemia (STSL), also referred to as phytosterolemia, is a rare autosomal recessive lipid metabolic disorder characterized by increased intestinal hyperabsorption and diminished biliary excretion of plant sterols, attributable to mutations in the ABCG5 or ABCG8 genes (Lu et al. 2002; Escola‐Gil et al. 2014). While genetic screening estimates the incidence at approximately 1 in 200,000, the reported clinical prevalence is closer to 1 in 1,000,000, suggesting substantial underdiagnosis or misdiagnosis (Tada et al. 2021). Individuals affected by STSL may present with a range of clinical manifestations, including xanthomas, arthralgia, hemolytic anemia, erythrocyte morphological abnormalities (e.g., stomatocytes), macrothrombocytopenia, splenomegaly, hepatic complications, atherosclerosis, early‐onset cardiovascular disease, and abnormal bleeding tendencies. Current therapeutic strategies primarily aim to restrict dietary intake of cholesterol and phytosterols, in conjunction with the administration of ezetimibe to reduce the absorption of plant sterols (Yoo 2016; Rocha et al. 2023). Nephronophthisis is another rare autosomal recessive genetic disorder characterized by damage to the tubular basement membrane and the formation of cysts within the renal medulla (Wolf and Hildebrandt 2011). More than 27 gene mutations have been identified in association with NPHP, with nephrocystin‐1 (NPHP1) mutation being the most prevalent. The prognosis for individuals affected by this condition is generally unfavorable, as it frequently results in end‐stage renal disease (ESRD) by the age of 30 (Wang et al. 2022). The concurrence manifestation of two distinct monogenic disorders in a single individual is clinically rare (Wadhwa et al. 2018). Research suggests that the combined prevalence of two genetic conditions accounts for approximately 4.3% of diagnosed genetic disorders, with a variability ranging from 1.4% to 7.2% (Posey et al. 2016; Balci et al. 2017; Tan et al. 2023). Herein, we report a comprehensive clinical and molecular analysis of a pediatric patient presenting with recurrent fever, anemia, thrombocytopenia, splenomegaly, and renal failure. Genetic testing ultimately confirmed that the child was affected by STSL due to a mutation in the ABCG8 gene, as well as NPHP associated with a mutation in the NPHP1 gene. Further systematic literature analysis was conducted of the genotypic and phenotypic characteristics of Chinese STSL patients. Materials and Methods Ethical Compliance The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Children's Hospital of Nanjing Medical University (No. 202502006‐1). Written informed consent was obtained from the patient and his parents. Immunohistochemical Staining Routine hematoxylin and eosin (H&E), Periodic acid‐Silver Methenamine (PASM), and Masson's trichrome staining were performed. For H&E staining, tissues were washed with normal saline, fixed in 10% formalin (48 h, 4°C), dehydrated in ethanol, paraffin‐embedded, sectioned (4 μm), and stained. PASM staining followed the same preparation as H&E. Sections were deparaffinized, hydrated, oxidized in 1% periodic acid (20 min, 40°C), incubated with methenamine silver solution at 60°C, treated with 0.1% gold chloride solution for 1 min and 2% sodium thiosulfate for 2 min, counterstained with Mayer's hematoxylin, dehydrated, and mounted. For Masson's trichrome staining, deparaffinized sections were fixed in Bouin's solution (1 h, 56°C), then sequentially stained with Weigert's hematoxylin, HCl/ethanol, Biebrich scarlet‐acid fuchsin, phosphomolybdic‐phosphotungstic acid, aniline blue, and acetic acid, followed by dehydration and resin mounting. The results were shown at 200× magnification. Molecular Genetic Analysis Whole exome sequencing (WES) and bioinformatic analysis were conducted by the Beijing Chigene Institute. DNA was extracted from the blood samples of the proband and his parents. Single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variations (CNVs) were analyzed using next‐generation sequencing (NGS) data. Pathogenic and likely pathogenic variants were validated by Sanger sequencing and underwent parental segregation analysis. Statistical Analyses All statistical analyses were conducted using R software (version 4.2.2). Categorical variables were presented as frequencies and percentages, with group comparisons performed using the chi‐square test (χ 2). A two‐sided p value of < 0.05 was considered statistically significant. The association between phenotypes and genotypes was assessed using logistic regression, with age and sex included as covariates. Fisher's exact test was used to calculate the p value when one group had zero events. Multiple comparisons were corrected using the Bonferroni method, with an adjusted significance threshold of p < 0.005. Results Case Presentation Patient Data A 10‐year‐old Chinese boy was admitted to a local hospital presenting with a 5‐day history of persistent pyrexia and anemia. Laboratory evaluations revealed significant hematological and metabolic derangements, including hemoglobin of 51 g/L, platelet count of 103 × 109/L, triglyceride (TG) of 4.19 mmol/L, total cholesterol (TC) of 6.64 mmol/L, and serum creatinine of 315.4 μmol/L. Despite negative bone marrow findings, the presence of splenomegaly and hyperferritinemia (602.0 μg/L) led to a presumptive diagnosis of hemophagocytic lymphohistiocytosis (HLH), and the patient subsequently received treatment with antibiotics and blood transfusions. Despite an initial reduction in fever, his hemoglobin and platelet levels persisted in their decline. Subsequently, the boy was administered oral dexamethasone in a dosage of 5.6 mg, three times daily. Due to a deterioration in renal function, the patient was referred to our center for advanced management. However, the patient's clinical course was complicated by chronic periarticular xanthomas on the elbows and knees, which had persisted since age 4 (Figure 1A–F). His parents and 16‐year‐old sibling were in good health, with no history of renal or metabolic disorders. Xanthoma phenotype in the proband. (A) Xanthoma on the left elbow. (B) Xanthoma on the left knee. (C) Chronic xanthoma on the right knee. (D–F) MRI of the xanthoma on the left elbow. (D) T1‐weighted imaging (T1WI). (E) T2‐weighted imaging (T2WI). (F) Proton density‐weighted imaging (PDWI). Arrow indicates xanthoma. Routine Clinical Data On admission, the patient exhibited normal blood pressure (127/80 mmHg) and age‐appropriate growth parameters (36.4 kg, 143 cm), with multiple soft, mobile, well‐circumscribed masses observed on the left elbow, knees, and ankles. Laboratory evaluation (Table 1) demonstrated: elevated urine α1‐microglobulin (55.6 mg/L) and serum creatinine (250 μmol/L), urine concentration (osmolality 205 mOsm/kg, specific gravity 1.008), and 24 h proteinuria (0.14 g) both in normal range. Hematologic findings included slightly elevated low‐density lipoprotein cholesterol (LDL‐C, 3.56 mmol/L), schistocytes on peripheral smear, elevated reticulocytes (4.82%) with negative Coomb's test, and metabolic acidosis (pH 7.264, HCO3 − 13.3 mmol/L, BE −12.5 mmol/L). Metabolic derangements comprised hypocalcemia (1.64 mmol/L), hyperphosphatemia (2.07 mmol/L), and markedly elevated PTH (1090 pg/mL). Inflammatory markers showed hypertriglyceridemia (2.09 mmol/L), hyperferritinemia (838.3 ng/mL), and elevated C5b‐9 (405 ng/mL [72–252]), while complement, fibrinogen, NK cell count, autoantibodies, and metabolic screens were unremarkable. Echocardiogram identified a patent foramen ovale with mild aortic regurgitation. TABLE 1Laboratory examination results of the proband in this study.Parameter (unit)ResultsReference rangeParameter (unit)ResultsReference rangeWBC (109/L)8.764.6–11.9TP (g/L)69.465–84Hb (g/dL)5.1121–158Alb (g/L)44.639–54Plt (109/L)103177–446LDH (U/L)269120–325BUN (mmol/L)21.222.7–7.0TG (mmol/L)2.090–1.7Cr (μmol/L)25027–66HDL‐C (mmol/L)0.661.16–1.42UA (mmol/L)559208–428TC (mmol/L)6.640–5.18NA (mmol/L)140.9135–145IgG (g/L)7.187.91–13.07K (mmol/L)3.443.7–5.2IgA (g/L)1.260.85–1.71Ca (mmol/L)1.642.1–2.8C3 (g/L)0.8770.88–2.01P (mmol/L)2.071.25–1.93C4 (g/L)0.1210.16–0.47ALT (U/L)287–30SF (μg/L)838.323.9–336.2AST (U/L)2314–44PTH (pg/mL)109016–87USG1.0081.003–1.03pH7.2647.35–7.45α1‐MG (mg/L)55.60–12.5SBC (mmol/L)13.322.0–24.024hrUpr (g)0.14< 0.15BE (mmol/L)−12.5−3.0 to 3.0Abbreviations: α1‐MG, urine α1‐macroglobulin; 24hrUpr, 24 h urinary albumin quantity; Alb, serum albumin; ALT, serum alanine aminotransferase; AST, serum aspartate aminotransferase; BE, base excess; BUN, blood urea nitrogen; C3, serum complement protein 3; C4, serum complement protein 4; Ca, serum calcium; Cr, serum creatinine; Hb, hemoglobin; HDL‐C, serum high‐density lipoprotein cholesterol; IgA, serum immunoglobulin A; IgG, serum immunoglobulin G; K, serum potassium; LDH, serum lactate dehydrogenase; NA, serum sodium; P, serum phosphorus; Plt, platelet; PTH, serum parathyroid hormone; SBC, standard bicarbonate radical; SF, serum ferritin; TC, serum total cholesterol; TG, serum triglyceride; TP, serum total protein; UA, serum uric acid; USG, urine specific gravity; WBC, white blood cell. Laboratory examination results of the proband in this study. Abbreviations: α1‐MG, urine α1‐macroglobulin; 24hrUpr, 24 h urinary albumin quantity; Alb, serum albumin; ALT, serum alanine aminotransferase; AST, serum aspartate aminotransferase; BE, base excess; BUN, blood urea nitrogen; C3, serum complement protein 3; C4, serum complement protein 4; Ca, serum calcium; Cr, serum creatinine; Hb, hemoglobin; HDL‐C, serum high‐density lipoprotein cholesterol; IgA, serum immunoglobulin A; IgG, serum immunoglobulin G; K, serum potassium; LDH, serum lactate dehydrogenase; NA, serum sodium; P, serum phosphorus; Plt, platelet; PTH, serum parathyroid hormone; SBC, standard bicarbonate radical; SF, serum ferritin; TC, serum total cholesterol; TG, serum triglyceride; TP, serum total protein; UA, serum uric acid; USG, urine specific gravity; WBC, white blood cell. In response to these findings, he received symptomatic management including: methylprednisolone (60 mg q12h × 7 days) for anti‐inflammatory control; packed RBC transfusions with erythropoietin for anemia; sodium bicarbonate for metabolic acidosis; and calcium plus active vitamin D (calcitriol) for mineral homeostasis. Despite these interventions, his condition failed to improve as anticipated, with ongoing recurrent fever and polyarthralgia accompanied by the development of large, tender xanthomas surrounding the affected joints. Pathological Results Renal biopsy demonstrated tubulointerstitial nephropathy with ischemic injury (Figure 2A–D). Ischemic glomerulopathy affected 38% (8/21) of glomeruli, showing segmental mesangial matrix expansion, basement membrane wrinkling, and Bowman's capsule fibrosis. Tubular findings included multifocal epithelial cell granular/vacuolar degeneration and 40%–50% tubular atrophy with associated lymphohistiocytic infiltration and interstitial fibrosis. Focal tubular dilation was observed. Vascular findings included small vessel intimal thickening with arterial hyalinization and endothelial hyperplasia. Immunofluorescence was negative for immune deposits. Renal biopsy of the proband. Kidney histology (×200). (A, B) The results of periodic acid‐silver methenamine (PASM). (C, D) The results of Masson's trichrome staining. (A) Segmental wrinkling of the glomerular basement membrane (arrow). (B, C) Glomerulosclerosis, segmental wrinkling of the glomerular basement membrane, fibrous hyperplasia of the Bowman's capsule wall, interstitial infiltration of lymphocytes and mononuclear cells, and fibrous tissue hyperplasia. (D) Vacuolar degeneration of renal tubular epithelial cells. Histopathological assessment of the xanthoma demonstrated foamy macrophages and spindle cell proliferation amid degenerated collagen, supporting a granulomatous diagnosis. Genetic Sequencing Genetic testing was initiated due to his complex clinical presentation, diagnostic uncertainty, and poor response to treatment. NGS (Chigene Institute, Beijing) identified compound heterozygous variants in ABCG8 [c.490C>T (exon 4) and c.323‐1G>C (intron 3)] (Figure 3), along with a homozygous deletion in NPHP1 spanning exons 1–20 (Figure 4). Both ABCG8 heterozygous variants have been previously reported in the literature. Parental testing confirmed that each parent carries one of the ABCG8 variants and the NPHP1 deletion in heterozygous state. His older brother was found to have no ABCG8 mutations and was identified as a carrier of a heterozygous NPHP1 deletion. Genetic profile of ABCG8 variants in the family. (A) Family pedigree. The blue arrow indicates the proband, who carried compound heterozygous variants in ABCG8 [c.490C>T (exon 4) and c.323‐1G>C (intron 3)]. His father was heterozygous for the ABCG8 [c.323‐1G>C (intron 3)] variant, and his mother was heterozygous for the ABCG8 [c.490C>T (exon 4)] variant. His brother was wild‐type for both alleles. (B, C) Verification by Sanger sequencing. (B) ABCG8 [c.323‐1G>C (intron 3)] variant. (C) ABCG8 [c.490C>T (exon 4)] variant. Arrows indicate the positions of nucleotide changes. Genetic profile of NPHP1 variants in the family. (A) Family pedigree. The blue arrow indicates the proband with a homozygous deletion in NPHP1 spanning exons 1–20. His parents and his brother were carriers of a heterozygous deletion. (B) Familial segregation analysis. Subsequent Treatment and Follow‐Up Following initial anti‐inflammatory and symptomatic treatment, the child achieved normal body temperature with improved anemia and thrombocytopenia. Twenty days after discharge, he developed recurrent fever, cough, arthralgia, and progressive enlargement of painful soft lumps, accompanied by declining hemoglobin and platelets. Despite treatment with piperacillin‐tazobactam and methylprednisolone (1 mg/kg/day), his symptoms persisted. Genetic testing subsequently confirmed dual ABCG8 and NPHP1 mutations. Immediate serum phytosterol analysis by gas chromatography–mass spectrometry (GC–MS) showed a significantly elevated level (866.01 μmol/L), confirming the diagnosis of STSL. After approximately 1 week of a low plant sterol diet and ezetimibe, his symptoms markedly improved, including reduced xanthelasma, normalized temperature, relieved joint pain, and resolved hematological abnormalities. However, due to poor compliance, the medications were discontinued after a few months. One year later, he progressed to ESRD and initiated peritoneal dialysis. Over the past 2 years, the child has maintained peritoneal dialysis while adhering to a plant sterol‐restricted diet, with subcutaneous erythropoietin injections and oral medications (ezetimibe, calcium, and active vitamin D). No recurrence of xanthomas or arthralgia has been observed, with hemoglobin levels stable at 100–130 g/L and platelets within normal range. His eGFR remained < 15 mL/min/1.73 m2. For financial reasons, he has not yet been placed on the kidney transplant waiting list. Phenotypic and Genotypic Analysis of Chinese Patients With STSL Scoping Review of STSL in Chinese Populations To comprehensively understand STSL in Chinese populations, we systematically reviewed literature using terms like “phytosterolemia” and “sitosterolemia” in Wanfang and China National Knowledge Infrastructure (CNKI), and searched PubMed with keywords including “Chinese” and “ABCG5,” “Chinese” and “ABCG8,” “Chinese” and “phytosterolemia,” or “Chinese” and “sitosterolemia.” We collected articles on STSL‐related gene mutations published between January 1974 and 2025. The literature screening flowchart is shown in Figure S1. After exclusion of duplicate cases based on reporting center, patient sex, age, pathogenic gene, and mutation site, a total of 131 cases (including the present case) were finally included (Table S1). Genotypic and Phenotypic Analysis of STSL in China A systematic review of 131 Chinese patients with phytosterolemia revealed a male‐to‐female ratio of 61:70, with pediatric cases (< 18 years) predominating (71.8%). Xanthomas were the most prevalent manifestation (n = 108, 82.4%), followed by splenomegaly (n = 42, 32.1%), arthralgia (n = 17, 13.0%), and fever (n = 4, 3.1%). Among those with splenomegaly, 59.5% (25/42) underwent splenectomy. The most common laboratory finding was hypercholesterolemia with elevated LDL‐C (82.4% of patients), followed by thrombocytopenia (32.1%), anemia (30.5%), liver damage (13.0%), and cardiovascular disorders (13.0%) (Figure 5A). After adjustment for age and sex, no significant differences were observed in any of the aforementioned symptoms and laboratory parameters between the ABCG5 and ABCG8 variant groups (p > 0.005) (Table 2). Genotypes and phenotypes of 131 Chinese sitosterolemia patients in the literature. (A) Phenotypic spectrum of 131 Chinese sitosterolemia patients. The prevalence of each clinical manifestation is presented as a percentage of affected individuals, including high low‐density lipoprotein cholesterol (LDL‐C), high total cholesterol (TC), xanthoma, splenomegaly, thrombocytopenia, anemia, arthralgia, cardiovascular involvement, liver damage, and fever. (B) Genotypic distribution of 131 Chinese sitosterolemia patients. The frequencies of mutation types are summarized. comp het, compound heterozygous mutations; hom, homozygous mutations. TABLE 2Phenotypic and genotypic analysis of 131 Chinese STSL patients based on different gene variants.Parameters ABCG5 variants (n = 101) ABCG8 variants (n = 30)OR (95% CI) p Xanthoma, n (%)83 (82.1)25 (83.3)1.18 (0.39, 3.23)0.755Thrombocytopenia, n (%)31 (30.7)11 (36.7)1.17 (0.38, 3.95)0.786Anemia, n (%)33 (32.7)7 (23.3)1.86 (0.73, 5.22)0.212Arthralgia, n (%)12 (11.9)5 (16.7)0.74 (0.24, 2.55)0.607High LDL‐C, n (%)83 (82.1)25 (83.3)0.94 (0.28, 2.87)0.916High TC, n (%)81 (80.2)27 (90.0)0.28 (0.06, 1.01)0.073Splenomegaly, n (%)29 (28.7)13 (43.3)0.58 (0.16, 2.20)0.408Splenectomy, n (%)15 (14.9)10 (33.3)0.12 (0.01, 0.80)0.063Liver damage, n (%)11 (10.9)6 (20.0)0.57 (0.18, 1.92)0.345Cardiovascular disease, n (%)13 (12.9)4 (13.3)1.18 (0.36, 4.70)0.794 Note: Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression, adjusted for age and sex. Multiple comparisons were corrected using the Bonferroni method, with an adjusted significance threshold of p < 0.005.Abbreviations: LDL‐C, serum low‐density lipoprotein cholesterol; STSL, sitosterolemia; TC, serum total cholesterol. Phenotypic and genotypic analysis of 131 Chinese STSL patients based on different gene variants. Note: Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression, adjusted for age and sex. Multiple comparisons were corrected using the Bonferroni method, with an adjusted significance threshold of p < 0.005. Abbreviations: LDL‐C, serum low‐density lipoprotein cholesterol; STSL, sitosterolemia; TC, serum total cholesterol. Literature review showed that ABCG5 mutations accounted for 77.1% (101/131) of Chinese STSL cases, with compound heterozygosity (58.0%) being more prevalent than homozygous mutations (19.1%). In contrast, ABCG8 mutations represented 22.9% of cases, also demonstrating a higher frequency of compound heterozygosity (16.0%) compared to homozygosity (6.9%) (Figure 5B). Common ABCG5 mutations included c.1336C>T (p.R446X; 38/101), c.751C>T (p.Q251X; 24/101), and c.904+1G>A (p.M302Nfs*82; 16/101). Among ABCG8 variants, the most frequently observed were c.788G>A (p.R263Q; 6/30) and c.694+5G>A (p.Y209Nfs*43; 5/30). We then performed phenotypic and genotypic analyses of these 131 STSL patients based on age groups (pediatrics < 18 years and adults ≥ 18 years) (Table 3). The results showed that the incidence of thrombocytopenia in adults (81.1%) was significantly higher than that in pediatrics (12.8%, p < 0.001). High TC and LDL‐C levels were observed in 87/94 (92.6%) pediatric patients, while the incidence in the adult group was significantly lower at only 56.8% (p < 0.001). No splenectomy events were observed among pediatric patients, whereas 25 adult patients (67.6%) had undergone splenectomy (Fisher's exact test, p < 0.001). TABLE 3Phenotypic and genotypic analysis of 131 Chinese STSL patients by age group.ParametersPediatric patients (n = 94)Adult patients (n = 37)OR (95% CI) p Xanthoma, n (%)79 (84.0)29 (78.4)1.43 (0.53, 3.70)0.463Thrombocytopenia, n (%)12 (12.8)30 (81.1)0.03 (0.01, 0.08) < 0.001 Anemia, n (%)24 (25.5)16 (43.2)0.41 (0.18, 0.93)0.033Arthralgia, n (%)12 (12.8)5 (13.5)0.90 (0.30, 3.08)0.859High LDL‐C, n (%)87 (92.6)21 (56.8)10.31 (3.80, 30.95) < 0.001 High TC, n (%)87 (92.6)21 (56.8)11.63 (4.21, 35.66) < 0.001 Splenomegaly, n (%)9 (9.6)33 (89.2)0.01 (0, 0.04) < 0.001 Liver damage, n (%)6 (6.4)11 (29.7)0.16 (0.05, 0.47) 0.001 Cardiovascular disease, n (%)7 (7.4)10 (27.0)0.20 (0.07, 0.59) 0.004 Note: Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression, adjusted for genotype and sex. Multiple comparisons were corrected using the Bonferroni method, with an adjusted significance threshold of p < 0.005. Bold indicates p < 0.005. No splenectomy events were observed in the pediatric group; therefore, regression estimation was not performed.Abbreviations: LDL‐C, serum low‐density lipoprotein cholesterol; STSL, sitosterolemia; TC, serum total cholesterol. Phenotypic and genotypic analysis of 131 Chinese STSL patients by age group. Note: Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression, adjusted for genotype and sex. Multiple comparisons were corrected using the Bonferroni method, with an adjusted significance threshold of p < 0.005. Bold indicates p < 0.005. No splenectomy events were observed in the pediatric group; therefore, regression estimation was not performed. Abbreviations: LDL‐C, serum low‐density lipoprotein cholesterol; STSL, sitosterolemia; TC, serum total cholesterol. Among adult patients, 33 (89.2%) had splenomegaly, 11 (29.7%) exhibited liver damage, and 10 (27.0%) had cardiovascular disease—all significantly higher than the corresponding rates in the pediatric group (9.6%, 6.4%, and 7.4%, respectively; p < 0.001, p = 0.001, p = 0.004). No significant differences were observed between the two groups in the prevalence of xanthoma, anemia, arthralgia, or splenectomy (p > 0.005). Moreover, ABCG5 was the predominant causative gene in both children and adults (79.8% and 70.3%, respectively). Discussion In this study, the proband was initially diagnosed with HLH because he presented with persistent fever, anemia, thrombocytopenia, hypertriglyceridemia, hypercholesterolemia, hyperferritinemia, and splenomegaly, fulfilling five of the eight HLH‐2004 diagnostic criteria and exhibiting a transient initial response to anti‐inflammatory therapy (Henter et al. 2007). However, the combination of chronic, infection‐exacerbated periarticular soft‐tissue masses (xanthomas), persistent arthralgia, and progressive renal dysfunction was atypical for HLH. Subsequent genetic sequencing elucidated a dual molecular etiology: biallelic ABCG8 variants driving STSL (which comprehensively accounted for the fever, anemia, macrothrombocytopenia, splenomegaly, arthralgia, and xanthomas) and a homozygous NPHP1 deletion driving NPHP (which correlated with the low‐molecular‐weight proteinuria, secondary renal anemia, and early‐onset ESRD). This case underscores the importance of genetic testing when clinical features conflict with initial diagnoses. With the rapid advances in genomic technologies, increasing cases of coexistence of two relatively rare inherited genetic disorders have been reported (Capra et al. 2023; Tan et al. 2023). Currently, only two cases of STSL with dual genetic diagnoses have been reported. Zhou et al. (2022) described one case (Patient P66) with coexisting STSL and glycogen storage disease type VI (GSD VI), while Tada et al. (2016) reported a Japanese girl with both STSL and familial Mediterranean fever. Through phenotypic and genotypic analyses, the coexisting pathogenic genes may (1) participate in the same biological process (Lyulcheva‐Bennett et al. 2024), (2) affect the same signaling pathway (Pavlovsky et al. 2022), or (3) show no apparent correlation (Walke et al. 2022). The ABCG8 gene, paired with ABCG5 on chromosome 2p21, encodes sterolin‐2 (while ABCG5 encodes sterolin‐1) (Berge et al. 2000; Williams et al. 2021). Expressed primarily in the liver, small intestine, and gallbladder epithelium, this tandem inhibits plant sterol absorption and promotes their excretion (Tada et al. 2021; Williams et al. 2021). NPHP1, located on chromosome 2q13, is predominantly expressed in the ciliary structures of cells including retinal photoreceptor cells and renal collecting duct epithelial cells (Li et al. 2021; Leggatt et al. 2023). NPHP1 mutations can cause ciliopathies (Soliman et al. 2012; McConnachie et al. 2021). Notably, this is the inaugural report of concurrent STSL and NPHP. At present, there is no established functional or epistatic interaction between ABCG8 and NPHP1. However, Xia et al. (2022) described a 55‐year‐old male (Patient P128) with STSL and carrying ABCG5 compound heterozygous mutations, who exhibited significant proteinuria and mild renal impairment (estimated glomerular filtration rate 71.3 mL/min/1.73 m2). These findings suggest renal involvement in STSL warrants long‐term monitoring. Given the rarity of STSL, large‐scale epidemiological and clinical cohorts remain scarce globally. In China, Xia et al. (2022) and Zhou et al. (2022) summarized relatively large cohorts (60 and 55 cases, respectively). This study, through a systematic literature review and exclusion of potentially duplicated cases, included 131 Chinese patients with STSL, representing the most comprehensive summary of cases in China to date. Among them, 71.8% were children, a proportion significantly higher than that of adults. This discrepancy may be influenced by the cohort reported by Xia et al., in which 55 of 60 patients were children. Long‐term follow‐up observations are still needed in the future. STSL exhibits highly heterogeneous clinical manifestations. Consistent with previous reports (Xia et al. 2022; Rocha et al. 2023), xanthomas were the most common phenotype (82.4%) in our literature review, followed by thrombocytopenia (32.1%). The incidence of splenomegaly in our cohort was also 32.1%, significantly higher than that reported by Xia et al. (2022). This discrepancy may be attributed to the higher prevalence of splenomegaly in adults, whereas Xia's cohort predominantly consisted of pediatric cases (91.7%). A small Brazilian STSL cohort (n = 14), which included a high proportion of adults, reported atherosclerotic cardiovascular disease (78.6%) and hematologic abnormalities (83%) as the most frequent manifestations (Tada et al. 2022). Similarly, in our summary cohort, both cardiovascular disease and thrombocytopenia were significantly more common in adults. Liver damage was also more frequently observed in adults. In contrast, elevated TC and LDL‐C levels were significantly more prevalent in children. This finding aligns with the fact that the overall rate of elevated TC and LDL‐C in our study (82.4%) was lower than that reported by Xia et al. (2022) (> 95%), likely due to their higher proportion of pediatric patients. Owing to its highly heterogeneous clinical spectrum, STSL is notoriously prone to misdiagnosis or significant diagnostic delays. Patients may be misdiagnosed with idiopathic thrombocytopenic purpura (ITP) or Evans syndrome due to thrombocytopenia and anemia (Wang et al. 2014; Cao et al. 2019), or with rheumatoid arthritis due to fever and arthralgia—for instance, Patient P15 endured recurrent fever and joint pain for 16 years, while Patient P36 received prolonged glucocorticoid therapy without benefit. Additionally, they may exhibit multisystem involvement, including fever, hematological disorders, arthralgia, splenomegaly, elevated ferritin, and increased ESR, necessitating differential diagnosis from HLH and systemic lupus erythematosus (SLE). More commonly, patients are misdiagnosed with familial hypercholesterolemia (FH) based on hypercholesterolemia, elevated LDL‐C, and xanthomas (Kawamura et al. 2018; Wang et al. 2018; Guay et al. 2024). Notably, 67.6% of Chinese STSL adult patients in our reviewed cases underwent splenectomy. However, some patients achieve good outcomes with dietary modifications alone (Huang et al. 2025), as demonstrated by our case where dietary control without regular ezetimibe maintained normal hemoglobin and platelets and prevented new xanthomas. Therefore, early diagnosis through sitosterol testing and genetic analysis is crucial to guide treatment and prevent severe complications, such as splenectomy, cardiac, and liver damage. Although the biopsy findings in this child support the diagnosis of tubulointerstitial nephropathy with only focal cystic dilation, consistent with early‐stage renal pathology in NPHP (Srivastava et al. 2017), the definitive diagnosis still relies on genetic testing. Similarly, the gold standard for diagnosing STSL is the identification of pathogenic homozygous or compound heterozygous mutations in either the ABCG5 or ABCG8 gene (Fong and Patel 2021; Tada et al. 2021). Notably, a recent study reported a Japanese girl with a heterozygous mutation in ABCG5 inherited from one parent and a variant in ABCG8 from the other, who exhibited classic STSL phenotypes (Tada, Nomura, et al. 2018). This finding suggests that the disease mechanism may involve more complex genetic interactions and warrants further investigation. As pathogenic variants can occur in both exonic and intronic regions (Colima Fausto et al. 2016; Xia et al. 2022), whole‐genome sequencing is recommended when clinical suspicion remains high despite negative exome sequencing results. Current evidence indicates that ABCG5 mutations are more prevalent in Asian populations, whereas ABCG8 mutations are more common in Caucasians (Tada, Nohara, et al. 2018; Leao et al. 2025). Consistent with this, our literature review found that ABCG5 mutations accounted for 77.1% of cases, with both pediatric and adult patients showing a higher prevalence of ABCG5 variants. The most prevalent ABCG5 mutations were c.1336C>T (37.6%), c.751C>T (23.8%), and c.904+1G>A (15.8%). Zhou et al.'s (2022) cohort, however, identified c.1336C>T, c.751C>T, and c.1166G>A as potential Chinese hot‐spot mutations, showing minor divergence from our findings. Larger cohort studies are warranted to clarify the mutation spectrum in Chinese STSL patients. Conclusion In conclusion, we report a dual molecular diagnosis of STSL and NPHP in a pediatric patient whose initial multisystem presentation mimicked HLH. Furthermore, a systematic review was conducted to summarize the clinical and genetic characteristics of previously reported Chinese STSL patients. As the largest and most comprehensive cohort summary of Chinese STSL patients to date, this study highlights the critical role of prompt genomic sequencing in resolving atypical multisystem presentations, thereby facilitating early, targeted interventions. Author Contributions Qiuxia Chen conceived and designed the study. Dan Ding, Hongmei Wu, and Fei Zhao diagnosed and treated the patient. Dan Ding, Hongmei Wu, and Bixia Zheng performed the systematic literature review and analyzed and interpreted the data. Dan Ding and Qiuxia Chen wrote the manuscript. All authors reviewed and approved the manuscript. Funding This work was supported by the Nanjing Health Science and Technology Development Special Fund Project under grant number YKK20120. Ethics Statement Ethical approval was obtained from the Ethics Committee of Children's Hospital of Nanjing Medical University (No. 202502006‐1), and adhered to the principles delineated in the Declaration of Helsinki. Written informed consent was obtained from the patient and his parents. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Figure S1: Literature screening flowchart. Table S1: Genotypes and phenotypes of 131 Chinese sitosterolemia patients in the literature.